Virobay
leaders in protease inhibitor design
Menlo Park, United States · Founded 2006 · $48.0M raised
- Headquarters
- Menlo Park, California
- Employees
- 1–10
- Founded
- 2006
- Business Model
- B2B
- Website
- virobayinc.com
- Total Funding
- $48.0M
- Last Round
- $8.0M Series BJul 2014
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Antiviral drug discovery and development company focused on treatments for autoimmune diseases, neuropathic pain, and viral infections.
Summary
Virobay is a Biotech company based in Menlo Park, United States, founded in 2006. It has raised $48.0M in total across 3 rounds, most recently a $8.0M Series B round in Jul 2014. Investors include Sutter Hill, Perceptive Advisors and TPG Biotechnology Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2014
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/virobay"><img src="https://indexed.vc/api/badge/company/virobay" alt="Virobay on Indexed.vc" width="260" height="76" /></a>